Lauriad^® is an innovative technology for high-performance delivery.
Lauriad^®: a new cutting edge technology with the potential of improving the use and efficiency of existing API.

Lauriad^®'s targeted action avoids the first-pass hepatic effect:

• • Limitation of drug interactions and adverse effects

Lauriad^®’s targeted action avoids gastrointestinal enzymatic degradation

Lauriad^® technology enables a targeted action at the site of infection by releasing an early, effective and prolonged concentration of an active substance:

• • Limitation of doses
  • Improving compliance
  • Improving treatment outcomes
  • ecology of drug taking